230 related articles for article (PubMed ID: 9754979)
1. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
Aziz I; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
3. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
Aziz I; Lipworth BJ
Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
[TBL] [Abstract][Full Text] [Related]
4. Concomitant administration of low-dose prednisolone protects against in vivo beta2-adrenoceptor subsensitivity induced by regular formoterol.
Tan KS; McFarlane LC; Lipworth BJ
Chest; 1998 Jan; 113(1):34-41. PubMed ID: 9440565
[TBL] [Abstract][Full Text] [Related]
5. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
Newnham DM; Grove A; McDevitt DG; Lipworth BJ
Thorax; 1995 May; 50(5):497-504. PubMed ID: 7597661
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
Lipworth BJ; Aziz I
Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
[TBL] [Abstract][Full Text] [Related]
8. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose.
Price D; Dutchman D; Mawson A; Bodalia B; Duggan S; Todd P;
Thorax; 2002 Sep; 57(9):791-8. PubMed ID: 12200524
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.
Newnham DM; McDevitt DG; Lipworth BJ
Am J Med; 1994 Jul; 97(1):29-37. PubMed ID: 7913292
[TBL] [Abstract][Full Text] [Related]
10. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
11. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK; Jackson CM; Bates CE; Lipworth BJ
Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
[TBL] [Abstract][Full Text] [Related]
12. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
14. Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients.
Tan KS; Grove A; McLean A; Gnosspelius Y; Hall IP; Lipworth BJ
Am J Respir Crit Care Med; 1997 Jul; 156(1):28-35. PubMed ID: 9230722
[TBL] [Abstract][Full Text] [Related]
15. Comparative trough effects of formoterol and salmeterol on lymphocyte beta2-adrenoceptor--regulation and bronchodilatation.
Aziz I; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1999 Aug; 55(6):431-6. PubMed ID: 10492055
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
17. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
Becker AB; Simons FE
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
[TBL] [Abstract][Full Text] [Related]
20. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.
Jones SL; Cowan JO; Flannery EM; Hancox RJ; Herbison GP; Taylor DR
Eur Respir J; 2001 Mar; 17(3):368-73. PubMed ID: 11405513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]